세계의 글리코믹스 시장 (2023-2030) : 제품별 (효소, 키트, 시약, 기기), 용도별 (신약 발견 및 개발, 진단), 최종 용도별, 지역별

■ 영문 제목 : Glycomics Market Size, Share & Trends Analysis Report, By Product (Enzymes, Kits, Reagents, Instruments), By Application (Drug Discovery & Development, Diagnostics), By End-use, By Region, And Segment Forecasts, 2023 - 2030

Grand View Research 회사가 출판한 조사자료로, 코드는 GRV23NOV018 입니다.■ 상품코드 : GRV23NOV018
■ 조사/발행회사 : Grand View Research
■ 발행일 : 2023년 9월
■ 페이지수 : 180
■ 작성언어 : 영어
■ 보고서 형태 : PDF
■ 납품 방식 : E메일 (납기:3일)
■ 조사대상 지역 : 세계
■ 산업 분야 : 재료
■ 판매가격 / 옵션 (부가세 10% 별도)
Single User (1인 열람용)USD5,950 ⇒환산₩8,032,500견적의뢰/주문/질문
Multi User (5인 열람용)USD6,950 ⇒환산₩9,382,500견적의뢰/주문/질문
Global/corporate License (기업 열람용)USD8,950 ⇒환산₩12,082,500견적의뢰/구입/질문
가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
글로벌 글리코믹스 시장의 성장 및 동향
Grand View Research사의 최신 보고서에 따르면, 세계의 글리코믹스 시장 규모는 2030년까지 49. 2억 달러에 달할 것으로 예상됩니다. 또한 2023년부터 2030년까지 14. 6%의 CAGR을 기록할 것으로 추정하고 있습니다. 다양한 생물학적 과정에서 글리코믹스의 중요한 역할로 인해 글리코믹스 분야의 연구 개발이 증가하면서 글로벌 시장을 견인할 것으로 예상됩니다. 또한, 글리코믹스가 당쇄 기반 진단 솔루션 개발에 중요한 역할을 하는 개인 맞춤형 의료에 대한 수요가 증가함에 따라 업계의 성장을 더욱 촉진하고 있습니다.

최근 글리코믹스는 다양한 건강 상태의 조기 발견 및 진단을 위한 질병 특이적 당류 바이오마커를 식별하는 데 있어 유망한 역할을 하고 있습니다. 당류 바이오마커의 잠재력은 의료 및 진단 업계의 관심을 끌고 있습니다. 예를 들어, 2021년 11월 글리코패스(GlycoPath Inc.)는 임상 및 연구 시료의 당단백질 분석용 당단백질 이미징 키트를 출시했습니다. 새로 출시된 키트는 조직 이미징에서 생체 유체 프로파일링까지 적용 가능하며, 다양한 플랫폼에 쉽게 적응할 수 있습니다.

기술 발전도 글리코믹스 장비에 대한 높은 수요에 기여하고 있습니다. 단백질 특성 분석과 같은 절차는 화학 및 생화학 연구에서 질량 분석(MS), 고성능 액체 크로마토그래피(HPLC), 모세관 전기영동(CE)과 같은 첨단 기술로 발전하고 있습니다. 이러한 첨단 기술을 통해 빠르고 정확한 결과를 얻을 수 있습니다. 현재 사용 가능한 글리코믹스 기술은 표준화되고 간소화되어 있습니다.

또한, 당쇄 기반 연구를 지원하는 연구 기관의 증가는 가까운 장래에 시장 성장을 촉진할 것으로 예상되는 주요 요인으로, National Center for Biomedical Glycomics (NCBG)는 분석 유전체학 기술 및 도구의 보급과 개발에 주력하고 있습니다. 이 센터의 분석 및 기술 연구 개발 프로그램에서는 당쇄 도구, 당쇄 복합체, 인포매틱스 개발이 이루어지고 있습니다. 또한, 국립암연구센터는 암 연구를 위한 당쇄의 구조와 기능을 연구하는 'Alliance of Glycobiologists for Cancer Research(암 연구를 위한 당생물학자 연합)'로 구성되어 있습니다.

글리코믹스 시장 보고서 주요 내용

- 2022년 효소 분야가 29. 2%의 매출 점유율을 차지할 것으로 예상되며, 이는 당쇄 기반 연구, 진단 및 신약개발에 효소가 광범위하게 적용되고 있기 때문입니다.

- 신약 개발 및 약물 개발이 시장에서 가장 큰 응용 분야인 반면, 진단 분야는 글리칸 기반 진단 개발에 대한 업계 플레이어들의 관심이 증가함에 따라 가장 빠르게 성장할 것으로 예상됩니다.

- 최종 용도별로는 학계 및 연구기관 분야가 38. 2%의 매출 점유율로 시장을 주도하고 있습니다. 높은 매출 성장은 연구 센터의 글리칸 구조 데이터 분석에 대한 광범위한 채택과 교육 및 훈련 목적으로 글리코믹스에 대한 선호도가 높아졌기 때문입니다.

- 2022년 세계 시장은 북미 지역이 39. 1%의 매출 점유율로 시장을 주도했습니다. 이 지역의 높은 성장세는 다수의 연구기관과 정부의 법제화 등의 요인에 의해 주도되고 있다고 전했습니다.
■ 보고서 개요

Chapter 1. 조사 방법 및 범위
Chapter 2. 개요
Chapter 3. 시장 변수/동향/범위
Chapter 4. 세계의 글리코믹스 시장 : 제품별 분석
Chapter 5. 세계의 글리코믹스 시장 : 용도별 분석
Chapter 6. 세계의 글리코믹스 시장 : 최종 용도별 분석
Chapter 7. 세계의 글리코믹스 시장 : 지역별 분석
Chapter 8. 경쟁 현황

■ 보고서 목차

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definition
1.1.1.1. Product Segment
1.1.1.2. Application Segment
1.1.1.3. End Use Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objective
1.4.1. Objective 1
1.4.2. Objective 2
1.4.3. Objective 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR’s Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information or Data Analysis:
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing focus on glycomics and proteomics research
3.2.1.2. Rising R & D investments by pharmaceutical and biotechnology companies
3.2.1.3. Technological advancements
3.2.1.4. Increasing focus on developing alternative to animal testing
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of glycomics instruments
3.2.2.2. Stringent government policies and regulations
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
4.1. Glycomics Market: Product Movement Analysis
4.2. Enzymes
4.2.1. Enzymes Market, 2018 – 2030 (USD Million)
4.2.2. Glycosidases
4.2.2.1. Glycosidases Market, 2018 – 2030 (USD Million)
4.2.3. Glycosyltransferases
4.2.3.1. Glycosyltransferases Market, 2018 – 2030 (USD Million)
4.2.4. Neuraminidases
4.2.4.1. Neuraminidases Market, 2018 – 2030 (USD Million)
4.2.5. Sialyltransferases
4.2.5.1. Sialyltransferases Market, 2018 – 2030 (USD Million)
4.2.6. Others
4.2.6.1. Others Market, 2018 – 2030 (USD Million)
4.3. Kits
4.3.1. Kits Market, 2018 – 2030 (USD Million)
4.3.2. Glycan labeling kits
4.3.2.1. Glycan labeling kits Market, 2018 – 2030 (USD Million)
4.3.3. Glycan purification kits
4.3.3.1. Glycan purification kits Market, 2018 – 2030 (USD Million)
4.3.4. Glycan release kits
4.3.4.1. Glycan release kits Market, 2018 – 2030 (USD Million)
4.3.5. Other glycomics kits
4.3.5.1. Other glycomics kits Market, 2018 – 2030 (USD Million)
4.4. Reagents
4.4.1. Reagents Market, 2018 – 2030 (USD Million)
4.4.2. Glycoproteins
4.4.2.1. Glycoproteins Market, 2018 – 2030 (USD Million)
4.4.3. Monosaccharides
4.4.3.1. Monosaccharides Market, 2018 – 2030 (USD Million)
4.4.4. Oligosaccharides
4.4.4.1. Oligosaccharides Market, 2018 – 2030 (USD Million)
4.4.5. Other reagents
4.4.5.1. Other reagents Market, 2018 – 2030 (USD Million)
4.5. Instruments
4.5.1. Instruments Market, 2018 – 2030 (USD Million)
4.5.2. Mass spectrometers
4.5.2.1. Mass spectrometers Market, 2018 – 2030 (USD Million)
4.5.3. HPLC
4.5.3.1. HPLC Market, 2018 – 2030 (USD Million)
4.5.4. MALDI-TOF
4.5.4.1. MALDI-TOF Market, 2018 – 2030 (USD Million)
4.5.5. Array systems
4.5.5.1. Array systems Market, 2018 – 2030 (USD Million)
4.5.6. Others
4.5.6.1. Others Market, 2018 – 2030 (USD Million)
Chapter 5. Application Business Analysis
5.1. Glycomics Market: Application Movement Analysis
5.2. Drug Discovery & Development
5.2.1. Drug Discovery & Development Market, 2018 – 2030 (USD Million)
5.3. Diagnostics
5.3.1. Diagnostics Market, 2018 – 2030 (USD Million)
5.4. Others
5.4.1. Others Market, 2018 – 2030 (USD Million)
Chapter 6. End Use Business Analysis
6.1. Glycomics Market: End Use Movement Analysis
6.2. Pharmaceutical & Biotechnology Companies
6.2.1. Pharmaceutical & Biotechnology Companies Market, 2018 – 2030 (USD Million)
6.3. Academic & Research Institutes
6.3.1. Academic & Research Institutes Market, 2018 – 2030 (USD Million)
6.4. Biopharmaceutical Companies
6.4.1. Biopharmaceutical Companies Market, 2018 – 2030 (USD Million)
6.5. CROs
6.5.1. CROs Market, 2018 – 2030 (USD Million)
Chapter 7. Regional Business Analysis
7.1. Glycomics Market Share By Region, 2022 & 2030
7.2. North America
7.2.1. North America Glycomics Market, 2018 – 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. Key Country Dynamics
7.2.2.2. Target Disease Prevalence
7.2.2.3. Competitive Scenario
7.2.2.4. U.S. Glycomics Market, 2018 – 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Key Country Dynamics
7.2.3.2. Target Disease Prevalence
7.2.3.3. Competitive Scenario
7.2.3.4. Canada Glycomics Market, 2018 – 2030 (USD Million)
7.3. Europe
7.3.1. Europe Glycomics Market, 2018 – 2030 (USD Million)
7.3.2. UK
7.3.2.1. Key Country Dynamics
7.3.2.2. Target Disease Prevalence
7.3.2.3. Competitive Scenario
7.3.2.4. UK Glycomics Market, 2018 – 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Key Country Dynamics
7.3.3.2. Target Disease Prevalence
7.3.3.3. Competitive Scenario
7.3.3.4. Germany Glycomics Market, 2018 – 2030 (USD Million)
7.3.4. France
7.3.4.1. Key Country Dynamics
7.3.4.2. Target Disease Prevalence
7.3.4.3. Competitive Scenario
7.3.4.4. France Glycomics Market, 2018 – 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Key Country Dynamics
7.3.5.2. Target Disease Prevalence
7.3.5.3. Competitive Scenario
7.3.5.4. Italy Glycomics Market, 2018 – 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Key Country Dynamics
7.3.6.2. Target Disease Prevalence
7.3.6.3. Competitive Scenario
7.3.6.4. Spain Glycomics Market, 2018 – 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Key Country Dynamics
7.3.7.2. Target Disease Prevalence
7.3.7.3. Competitive Scenario
7.3.7.4. Denmark Glycomics Market, 2018 – 2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Key Country Dynamics
7.3.8.2. Target Disease Prevalence
7.3.8.3. Competitive Scenario
7.3.8.4. Sweden Glycomics Market, 2018 – 2030 (USD Million)
7.3.9. Norway
7.3.9.1. Key Country Dynamics
7.3.9.2. Target Disease Prevalence
7.3.9.3. Competitive Scenario
7.3.9.4. Norway Glycomics Market, 2018 – 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Glycomics Market, 2018 – 2030 (USD Million)
7.4.2. Japan
7.4.2.1. Key Country Dynamics
7.4.2.2. Target Disease Prevalence
7.4.2.3. Competitive Scenario
7.4.2.4. Japan Glycomics Market, 2018 – 2030 (USD Million)
7.4.3. China
7.4.3.1. Key Country Dynamics
7.4.3.2. Target Disease Prevalence
7.4.3.3. Competitive Scenario
7.4.3.4. China Glycomics Market, 2018 – 2030 (USD Million)
7.4.4. India
7.4.4.1. Key Country Dynamics
7.4.4.2. Target Disease Prevalence
7.4.4.3. Competitive Scenario
7.4.4.4. India Glycomics Market, 2018 – 2030 (USD Million)
7.4.5. Australia
7.4.5.1. Key Country Dynamics
7.4.5.2. Target Disease Prevalence
7.4.5.3. Competitive Scenario
7.4.5.4. Australia Glycomics Market, 2018 – 2030 (USD Million)
7.4.6. Thailand
7.4.6.1. Key Country Dynamics
7.4.6.2. Target Disease Prevalence
7.4.6.3. Competitive Scenario
7.4.6.4. Thailand Glycomics Market, 2018 – 2030 (USD Million)
7.4.7. South Korea
7.4.7.1. Key Country Dynamics
7.4.7.2. Target Disease Prevalence
7.4.7.3. Competitive Scenario
7.4.7.4. South Korea Glycomics Market, 2018 – 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Glycomics Market, 2018 – 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Key Country Dynamics
7.5.2.2. Target Disease Prevalence
7.5.2.3. Competitive Scenario
7.5.2.4. Brazil Glycomics Market, 2018 – 2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key Country Dynamics
7.5.3.2. Target Disease Prevalence
7.5.3.3. Competitive Scenario
7.5.3.4. Mexico Glycomics Market, 2018 – 2030 (USD Million)
7.5.4. Argentina
7.5.4.1. Key Country Dynamics
7.5.4.2. Target Disease Prevalence
7.5.4.3. Competitive Scenario
7.5.4.4. Argentina Glycomics Market, 2018 – 2030 (USD Million)
7.6. MEA
7.6.1. MEA Glycomics Market, 2018 – 2030 (USD Million)
7.6.2. South Africa
7.6.2.1. Key Country Dynamics
7.6.2.2. Target Disease Prevalence
7.6.2.3. Competitive Scenario
7.6.2.4. South Africa Glycomics Market, 2018 – 2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Key Country Dynamics
7.6.3.2. Target Disease Prevalence
7.6.3.3. Competitive Scenario
7.6.3.4. Saudi Arabia Glycomics Market, 2018 – 2030 (USD Million)
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Target Disease Prevalence
7.6.4.3. Competitive Scenario
7.6.4.4. UAE Glycomics Market, 2018 – 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Key Country Dynamics
7.6.5.2. Target Disease Prevalence
7.6.5.3. Competitive Scenario
7.6.5.4. Kuwait Glycomics Market, 2018 – 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Share/Position Analysis, 2022
8.4. Company Profiles/Listing
8.4.1. Thermo Fisher Scientific, Inc
8.4.1.1. Overview
8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Merck KGaA
8.4.2.1. Overview
8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Agilent Technologies Inc.
8.4.3.1. Overview
8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Bruker
8.4.4.1. Overview
8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. New England Biolabs
8.4.5.1. Overview
8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Shimadzu Corporation
8.4.6.1. Overview
8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. Waters Corporation
8.4.7.1. Overview
8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Takara Bio Inc
8.4.8.1. Overview
8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Asparia Glycomics
8.4.9.1. Overview
8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. RayBiotech Life, Inc.
8.4.10.1. Overview
8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives

List of Tables

TABLE 1 List of Secondary Sources
TABLE 2 List of Abbreviations
TABLE 3 Regulatory Framework
TABLE 4 Global Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 5 Global Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 6 Global Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 7 Global Glycomics Market, By Region, 2018 - 2030 (USD Million)
TABLE 8 North America Glycomics Market, By Country, 2018 - 2030 (USD Million)
TABLE 9 North America Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 10 North America Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 11 North America Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 12 U.S. Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 13 U.S. Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 14 U.S. Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 15 Canada Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 16 Canada Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 17 Canada Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 18 Europe Glycomics Market, By Country, 2018 - 2030 (USD Million)
TABLE 19 Europe Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 20 Europe Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 21 Europe Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 22 UK Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 23 UK Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 24 UK Glycomics Market, By End-Use, 2018 - 2030 (USD Million),
TABLE 25 Germany Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 26 Germany Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 27 Germany Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 28 France Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 29 France Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 30 France Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 31 Spain Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 32 Spain Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 33 Spain Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 34 Italy Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 35 Italy Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 36 Italy Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 37 Denmark Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 38 Denmark Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 39 Denmark Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 40 Norway Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 41 Norway Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 42 Norway Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 43 Sweden Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 44 Sweden Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 45 Sweden Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 46 Asia Pacific Glycomics Market, By Country, 2018 - 2030 (USD Million)
TABLE 47 Asia Pacific Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 48 Asia Pacific Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 49 Asia Pacific Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 50 China Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 51 China Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 52 China Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 53 Japan Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 54 Japan Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 55 Japan Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 56 India Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 57 India Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 58 India Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 59 South Korea Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 60 South Korea Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 61 South Korea Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 62 Australia Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 63 Australia Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 64 Australia Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 65 Thailand Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 66 Thailand Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 67 Thailand Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 68 Latin America Glycomics Market, By Country, 2018 - 2030 (USD Million)
TABLE 69 Latin America Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 70 Latin America Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 71 Latin America Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 72 Brazil Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 73 Brazil Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 74 Brazil Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 75 Mexico Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 76 Mexico Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 77 Mexico Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 78 Argentina Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 79 Argentina Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 80 Argentina Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 81 MEA Glycomics Market, By Country, 2018 - 2030 (USD Million)
TABLE 82 MEA Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 83 MEA Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 84 MEA Glycomics Market, By End-Use, 2018 - 2030 (USD Million),
TABLE 85 South Africa Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 86 South Africa Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 87 South Africa Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 88 UAE Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 89 UAE Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 90 UAE Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 91 Saudi Arabia Glycomics Market, By Product, 2018 - 2030 (USD Million),
TABLE 92 Saudi Arabia Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 93 Saudi Arabia Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
TABLE 94 Kuwait Glycomics Market, By Product, 2018 - 2030 (USD Million)
TABLE 95 Kuwait Glycomics Market, By Application, 2018 - 2030 (USD Million)
TABLE 96 Kuwait Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
보고서 이미지

※본 조사보고서 [세계의 글리코믹스 시장 (2023-2030) : 제품별 (효소, 키트, 시약, 기기), 용도별 (신약 발견 및 개발, 진단), 최종 용도별, 지역별] (코드 : GRV23NOV018) 판매에 관한 면책사항을 반드시 확인하세요.
※본 조사보고서 [세계의 글리코믹스 시장 (2023-2030) : 제품별 (효소, 키트, 시약, 기기), 용도별 (신약 발견 및 개발, 진단), 최종 용도별, 지역별] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!